Moneycontrol PRO
HomeNewsBusinessHUL yet to decide on restarting operations at 3 manufacturing plants that saw COVID cases

HUL yet to decide on restarting operations at 3 manufacturing plants that saw COVID cases

The three manufacturing plants are located at Haridwar in Uttarakhand, South of India (erstwhile GSK plant) and in West Bengal.

July 21, 2020 / 21:18 IST
     
     
    26 Aug, 2025 12:21
    Volume
    Todays L/H
    More

    Hindustan Unilever, India’s largest FMCG firm that shut its three manufacturing plants due to COVID positive cases is yet to decide when operations will resume at these plants.

    In a media call post the announcement of April-June results, Sanjiv Mehta Chairman and Managing Director said, “We are following all operation standards of hygiene. We are going for extensive testing of all employees of these 3 factories.”

    The three manufacturing plants are located at Haridwar in Uttarakhand, South of India (erstwhile GSK plant), and in West Bengal.

    “The total employee strength of these factories is around 5,000 employees and only a small percentage of employees were tested positive," Mehta said, adding that of this 80-85% of employees were asymptomatic. As an added precaution, HUL decided to close the site to ensure deep cleaning and sanitisation before restarting operations.

    On July 19, HUL had said it temporarily closed down its Haridwar plant, where several of its employees have been tested positive for Covid-19.

    COVID-19 Vaccine

    Frequently Asked Questions

    View more
    How does a vaccine work?

    A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

    How many types of vaccines are there?

    There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

    What does it take to develop a vaccine of this kind?

    Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

    View more
    Show

    The company did not disclose the exact number of employees that were tested positive, but media reports suggest that 33 employees were tested positive in the Haridwar factory. The number of positive cases in the West Bengal and South of India factories is not known. 

    FMCG major Hindustan Unilever on July 21 has reported a standalone profit of Rs 1,881 crore for the quarter ended June 2020, increasing 7.2 percent compared to the previous quarter, supported by sharp fall (down 31.4 percent) in advertising and promotion expenses, and strong double-digit growth in foods & refreshment segment. However, it was impacted by exceptional expenses with respect to restructuring and acquisition.

    Himadri Buch
    Himadri Buch
    first published: Jul 21, 2020 08:36 pm

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347
    CloseOutskill Genai